Hivid


Also found in: Dictionary, Thesaurus.
Related to Hivid: Rescriptor, Zerit, Agenerase

Hivid

a trademark for an antiretroviral nucleoside analog (zalcitabine).

Hivid

Zalcitabine, see there. See AIDS, ddC.
References in periodicals archive ?
With its completely digital projection technology, the MultiSync HiVid 3500 HLO projector offers unique image quality advantages not available with other projection systems," said Dan Zubic, product manager with NEC Technologies' Visual Systems Division.
NEC Technologies has taken Texas Instruments' Digital Light processing(TM)(DLP(R)) technology to new heights by adding image enhancement and control features exclusive to the MultiSync HiVid 3500 HLO projector.
The MultiSync HiVid 3500 projector features an exclusive high performance motion adaptive three dimensional image processing that greatly improves NTSC video reproduction, far exceeding the image quality of any other LCD- or DLP-type high light output projector.
The MultiSync HiVid 3500 employs NEC's exclusive AccuZone(TM) adjustment technology to achieve near-perfect edge-to-edge brightness and white uniformity.
The MultiSync HiVid 3500 boasts ultra-high 3500+ ANSI lumens brightness, superior color saturation, an impressive 250:1 contrast ratio, and a precise 848 x 600 native resolution.
The MultiSync HiVid 3500 HLO projector has a suggested retail price (SRP) of $64,995.
The results confirm the clinical benefit of Invirase and Hivid over ddC monotherapy.
The study, called NV14256, is a phase III randomized, double blind comparison of Hivid, Invirase, and the combination of Invirase and Hivid in 978 HIV-infected patients with CD4 cell counts (measure of immune system) between 50-300 and with 16 or more weeks of prior AZT therapy.
The medium duration of prior AZT therapy was 68 weeks in the Invirase plus Hivid group.
Slightly more patients in the Invirase and Hivid group than in the monotherapy arms completed the protocol, and discontinuations for protocol-mandated toxicity was highest in the Hivid arm.
The current indication is based on changes in surrogate markers in patients who initiated Invirase concomitantly either with AZT (in previously untreated patients) or Hivid (in patients previously treated with prolonged AZT therapy).
a research-based health care company, has a long history in the area of HIV that includes Hivid, Invirase, Cytovene(R), Vitrasert(TM) (Vitrasert is a trademark of Chiron Vision), Roferon-A(R) and Bactrim(TM).